Skip to main content
. 2021 May 20;55(5):1019–1035. doi: 10.1007/s43441-021-00302-y

Fig. 2.

Fig. 2

FDA review divisions responsible for the 45 product approvals relying on external controls (2000–2019, select therapeutic areas)